Literature DB >> 15041034

Acetylcholine mediated vasodilatation in the microcirculation of patients with chronic fatigue syndrome.

V A Spence1, F Khan, G Kennedy, N C Abbot, J J F Belch.   

Abstract

The aetiology of chronic fatigue syndrome (CFS) remains controversial and a number of hypotheses have been put forward to explain it. Research into the condition is hindered by the considerable heterogeneity seen across patients but several reports have highlighted disturbances to cholinergic mechanisms in terms of central nervous system activity, neuromuscular function and autoantibodies to muscarinic cholinergic receptors. This paper examines an altogether separate function for acetylcholine and that is its role as an important and generalized vasodilator. Most diseases are accompanied by a blunted response to acetylcholine but the opposite is true for CFS. Such sensitivity is normally associated with physical training so the finding in CFS is anomalous and may well be relevant to vascular symptoms that characterise many patients. There are several mechanisms that might lead to ACh endothelial sensitivity in CFS patients and various experiments have been designed to unravel the enigma. These are reported here.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15041034     DOI: 10.1016/j.plefa.2003.12.016

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  3 in total

Review 1.  Special problems of children with myalgic encephalomyelitis/chronic fatigue syndrome and the enteroviral link.

Authors:  J Colby
Journal:  J Clin Pathol       Date:  2006-08-25       Impact factor: 3.411

Review 2.  Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Authors:  Leonard A Jason; Marcie L Zinn; Mark A Zinn
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

3.  Peripheral vascular responses to acetylcholine as a predictive tool for response to cholinesterase inhibitors in Alzheimer's disease.

Authors:  Peter J Connelly; Fiona Adams; Ziad I Tayar; Faisel Khan
Journal:  BMC Neurol       Date:  2019-05-03       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.